- Home
- ENSC vs IBG Comparison
ENSC vs IBG Comparison
Compare ENSC & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- IBG
- Stock Information
- Founded
- ENSC 2003
- IBG 2018
- Country
- ENSC United States
- IBG Australia
- Employees
- ENSC N/A
- IBG N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- ENSC Health Care
- IBG Consumer Staples
- Exchange
- ENSC Nasdaq
- IBG Nasdaq
- Market Cap
- ENSC 4.9M
- IBG 6.0M
- IPO Year
- ENSC N/A
- IBG 2024
- Fundamental
- Price
- ENSC $2.16
- IBG $0.59
- Analyst Decision
- ENSC
- IBG Strong Buy
- Analyst Count
- ENSC 0
- IBG 1
- Target Price
- ENSC N/A
- IBG N/A
- AVG Volume (30 Days)
- ENSC 53.2K
- IBG 75.6K
- Earning Date
- ENSC 08-13-2025
- IBG 07-22-2025
- Dividend Yield
- ENSC N/A
- IBG N/A
- EPS Growth
- ENSC N/A
- IBG N/A
- EPS
- ENSC N/A
- IBG N/A
- Revenue
- ENSC $6,224,081.00
- IBG $2,931,243.00
- Revenue This Year
- ENSC N/A
- IBG N/A
- Revenue Next Year
- ENSC $1,381.48
- IBG N/A
- P/E Ratio
- ENSC N/A
- IBG N/A
- Revenue Growth
- ENSC 256.35
- IBG N/A
- 52 Week Low
- ENSC $1.62
- IBG $0.44
- 52 Week High
- ENSC $14.67
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- ENSC 46.61
- IBG N/A
- Support Level
- ENSC $1.97
- IBG N/A
- Resistance Level
- ENSC $2.40
- IBG N/A
- Average True Range (ATR)
- ENSC 0.16
- IBG 0.00
- MACD
- ENSC 0.00
- IBG 0.00
- Stochastic Oscillator
- ENSC 44.19
- IBG 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.